Aptevo Therapeutics Inc. Capital Expenditure, Discontinued Operations
Aptevo Therapeutics Inc. (APVO) reported Capital Expenditure, Discontinued Operations of $0 for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-13.
Discontinued › Notes › Discontinued Operations and Disposal Groups
us-gaap:CapitalExpenditureDiscontinuedOperations · last filed 2020-05-13
- Aptevo Therapeutics Inc. capital expenditure, discontinued operations for the quarter ending 2020-03-31 was $0.00.
- Aptevo Therapeutics Inc. capital expenditure, discontinued operations for the quarter ending 2019-03-31 was $0.00.
| Period end | Capital Expenditure, Discontinued Operations 3 month |
|---|---|
| 2020-03-31 | $0.00 10-Q · filed 2020-05-13 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |